35例妊娠期结核性胸膜炎患者临床诊疗结果分析

doi:10.3969/j.issn.1000-6621.2020.07.016

摘要/Abstract

摘要：

目的探讨妊娠期结核性胸膜炎患者的临床特点。方法回顾性分析解放军总医院第八医学中心全军结核病研究所2011年3月至2018年12月收治的35例妊娠期结核性胸膜炎患者的临床资料。患者年龄20~41岁,平均年龄(27.60±5.45)岁。早期妊娠6例(17.1%),中期妊娠16例(45.7%),晚期妊娠12例(34.3%),产褥期1例(2.9%)。结果 35例患者中,13例经超声引导下胸膜活检组织病理学检查结果符合结核病而确诊,22例根据结核性胸膜炎临床诊断标准确定诊断。35例患者发热占82.9%(29/35),呼吸困难、咳嗽分别占77.1%(27/35)和57.1%(20/35)。早期人工流产5例,自然流产1例,中期引产13例,继续妊娠至分娩15例,包括3例中期妊娠及全部12例晚期妊娠者,产褥期发病1例。35例患者诊断明确后均给予抗结核药品治疗,经治疗临床症状及胸腔积液消失,无死亡患者;随诊6~55个月,未发现复发患者。16名新生儿中有1名早产儿为低出生体质量,余15名均为足月健康新生儿,未发现新生儿先天畸形。对新生儿随访7~55个月,未发现生长发育异常,也未患结核病。结论妊娠期结核性胸膜炎以临床诊断为主,进行积极的抗结核药品治疗效果明显,并且未对胎儿产生不良影响。

关键词: 妊娠并发症, 感染性, 结核, 胸膜, 胸腔积液, 治疗结果

Abstract:

Objective To investigate the clinical characteristics of pregnant tuberculous pleurisy patients. Methods We analyzed the retrospective clinical data from 35 cases with pregnancy complicated with tuberculous pleurisy admitted in the Tuberculosis Research Institute of the 8th Medical Center of Chinese PLA General Hospital during March 2011 to December 2018. Patients were 20-41 years old,average age was 27.60±5.45 years. 6 cases (17.1%) were during their early pregnancy,16 cases (45.7%) in mid-pregnancy, 12 cases (34.3%) in late pregnancy and 1 case (2.9%) in puerperium. Results Of 35 patients,13 definite cases were confirmed by histopathological examination with samples collected with ultrasound-guided pleural biopsy,22 cases were clinically diagnosed according to the clinical diagnostic criteria of tuberculous pleurisy. Fever occurred in 82.9% (29/35) of cases, dyspnea and cough accounted for 77.1% (27/35) and 57.1% (20/35) respectively. Among them,5 cases suffered early artificial abortion, 1 case got spontaneous abortion, 13 cases got induction of labor in mid-pregnancy,15 cases continued pregnancy until delivery (3 cases in mid-pregnancy and all 12 cases in late pregnancy), 1 case occurred in puerous period. All patients were treated with anti-tuberculosis drugs after the diagnosis was confirmed, then their clinical symptoms disappeared and pleural effusion were absorbed with no deaths. Patients were followed up for 6 to 55 months and no relapse cases were detected. One of the 16 newborns was premature with low birth weight,the other 15 were healthy term infants, no birth defects were found. The newborns were followed up for 7 to 55 months, no abnormality of growth or development, or tuberculosis were observed. Conclusion Pregnant tuberculous pleurisy patients are mainly diagnosed clinically. The anti-tuberculosis treatment is effective and no adverse effects on fetuses are found.

Key words: Pregnancy complications, infectious, Tuberculosis, pleural, Pleural effusion, Treatment outcome

刘琳. 35例妊娠期结核性胸膜炎患者临床诊疗结果分析[J]. 中国防痨杂志, 2020, 42(7): 731-736. doi: 10.3969/j.issn.1000-6621.2020.07.016

LIU Lin. Clinical analysis of 35 pregnant tuberculous pleurisy patients[J]. Chinese Journal of Antituberculosis, 2020, 42(7): 731-736. doi: 10.3969/j.issn.1000-6621.2020.07.016

参考文献 27

[1]	Ye R, Wang C, Zhao L, et al. Characteristics of miliary tuberculosis in pregnant women after in vitro fertilization and embryo transfer. Int J Tuberc Lung Dis, 2019,23(2):136-139. doi: 10.5588/ijtld.18.0223.
[2]	段纯, 喻艳林. 妊娠合并结核病的研究进展. 中华传染病杂志, 2018,36(5):317-320. doi: 10.3760/cma.j.issn.1000-6680.2018.05.016.
[3]	孙秀利, 任倍莹, 许军丽. 不同治疗时机对妊娠并发肺结核患者结局的影响. 中国防痨杂志, 2016,38(9):747-750. doi: 10.3969/j.issn.1000-6621.2016.09.011.
[4]	Sugarman J, Colvin C, Moran AC, et al. Tuberculosis in pregnancy: an estimate of the global burden of disease. Lancet Glob Health, 2014,2(12):e710-716. doi: 10.1016/S2214-109X(14)70330-4.
[5]	中华人民共和国国家卫生和计划生育委员会. WS 288—2017 肺结核诊断, 201711-09.
[6]	中华医学会. 临床诊疗指南:结核病分册, 北京: 人民卫生出版社, 2005: 10-12.
[7]	Light RW, Macgregor MI, Luchsinger PC, et al. Pleural effusions: the diagnostic separation of transudates and exudates. Ann Intern Med, 1972,77(4):507-513. doi: 10.7326/0003-4819-77-4-507.
[8]	乔玉环, 李留霞, 孙莹璞. 妇产科学, 北京: 人民军医出版社, 2006: 25-27.
[9]	Wolf B, Krasselt de, de Fallois J, et al. Tuberculosis in pregnancy-a summary. Geburtshilfe Frauenheilkd, 2019,79(4):358-365. doi: 10.1055/a-0774-7924.
[10]	Sobhy S, Babiker Z, Zamora J, et al. Maternal and perinatal mortality and morbidity associated with tuberculosis during pregnancy and the postpartum period: a systematic review and meta-analysis. BJOG, 2017,124(5):727-733. doi: 10.1111/1471-0528.14408.
[11]	唐神结, 高文. 临床结核病学.2版. 北京: 人民卫生出版社, 2019: 786-792.
[12]	宋斌, 卢水华. 预防结核病母婴传播的对策[J/OL]. 新发传染病电子杂志, 2017,2(3):138-142. doi: 10.3877/j.issn.2096-2738.2017.03.004.
[13]	徐晓红, 滕红. 妊娠合并结核病的管理[J/OL]. 中华产科急救电子杂志, 2017,6(3):161-165. doi: 10.3877/cma.j.issn.2095-3259.2017.03.007.
[14]	Nguyen HT, Pandolfini C, Chiodini P, et al. Tuberculosis care for pregnant women: a systematic review. BMC Infect Dis, 2014,14:617. doi: 10.1186/s12879-014-0617-x.
[15]	黄凌佳, 杨舒奇, 韩杰霞, 等. 妊娠合并结核的相关研究进展. 中国生育健康杂志, 2019,30(1):91-93.doi: 10.3969/j.issn.1671-878x.2019.01.024.
[16]	Asghar MU, Mehta SS, Cheema HA, et al. Sputum smear and culture-negative tuberculosis with associated pleural effusion: a diagnostic challenge. Cureus, 2018,10(10):e3513. doi: 10.7759/cureus.3513.
[17]	Bielsa S, Acosta C, Pardina M, et al. Tuberculous pleural effusion: clinical characteristics of 320 patients. Arch Bronconeumol, 2019,55(1):17-22. doi: 10.1016/j.arbres.2018.04.014.
[18]	杨新婷, 关国英, 王亚红, 等. 结核性胸膜炎的临床特征及诊断技术分析. 中国防痨杂志, 2017,39(11):1162-1168.doi: 10.3969/j.issn.1000-6621.2017.11.003.
[19]	Jo T, Kuse N, Inomata M, et al. Efficacy and safety of semi-flexible thoracoscopic cryobiopsy in the diagnosis of elderly tuberculous pleurisy. Respir Med Case Rep, 2020,29:101008. doi: 10.1016/j.rmcr.2020.101008.
[20]	黄毅, 杨翰, 冯璇, 等. 超声引导下获取标本行病理学与结核相关检测对结核性胸膜炎的诊断价值. 中国防痨杂志, 2019,41(8):833-837.doi: 10.3969/j.issn.1000-6621.2019.08.006.
[21]	曹兵生, 张蕊, 张更臣, 等. 超声引导下胸膜活检诊断结核性胸膜炎影响因素分析. 中华老年多器官疾病杂志, 2016,15(7):516-518.doi: 10.11915/j.issn.1671-5403.2016.07.122.
[22]	中华人民共和国卫生部疾病预防控制局, 中华人民共和国卫生部医政司, 中国疾病预防控制中心. 中国结核病防治规划实施工作指南(2008年版). 北京: 中国协和医科大学出版社, 2009.
[23]	周开元, 周红丽. 观察肾上腺皮质激素对结核性胸膜炎的临床疗效. 中国社区医师, 2019,35(15):81-83.doi: 10.3969/j.issn.1007-614x.2019.15.056.
[24]	Sun F, Li L, Liao X, et al. Adjunctive use of prednisolone in the treatment of free-flowing tuberculous pleural effusion: A retro-spective cohort study. Respir Med, 2018,139:86-90. doi: 10.1016/j.rmed.2018.05.002.
[25]	Xie S, Lu L, Li M, et al. The efficacy and safety of adjunctive corticosteroids in the treatment of tuberculous pleurisy: a systematic review and meta-analysis. Oncotarget, 2017,8(47):83315-83322. doi: 10.18632/oncotarget.18160.
[26]	Ryan H, Yoo J, Darsini P, et al. Corticosteroids for tuberculous pleurisy. Cochrane Database Syst Rev, 2017,3:CD001876. doi: 10.1002/14651858.CD001876.pub3.
[27]	吴华, 章友康. 妊娠及哺乳期女性糖皮质激素和免疫抑制剂的合理应用[J/OL]. 中华肾脏研究电子杂志, 2018,7(6):241-244.doi: 10.3877/cma.j.issn.2095-3216.2018.06.001.